Xcell Biosciences
Biotechnology, Health Diagnostics, Manufacturing, Medical, Therapeutics
Founded in 1/1/12
San Francisco, California, United States
For Profit
About Xcell Biosciences
Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 14 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 39600000 USD
- Last Funding: 27500000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Xcell Biosciences actively uses 14 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Diagnostics, Manufacturing, Medical, Therapeutics
Headquarters: San Francisco, California, United States
Leadership
- Shannon Eaker - CTO LinkedIn
Employees
- Brian Feth - Chief Executive Officer / Founder (LinkedIn)
- James Lim - Chief Scientific Officer (LinkedIn)